AU7542800A - Process for the preparation of paroxetine hydrochloride acetone solvate - Google Patents

Process for the preparation of paroxetine hydrochloride acetone solvate

Info

Publication number
AU7542800A
AU7542800A AU75428/00A AU7542800A AU7542800A AU 7542800 A AU7542800 A AU 7542800A AU 75428/00 A AU75428/00 A AU 75428/00A AU 7542800 A AU7542800 A AU 7542800A AU 7542800 A AU7542800 A AU 7542800A
Authority
AU
Australia
Prior art keywords
preparation
paroxetine hydrochloride
acetone solvate
hydrochloride acetone
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75428/00A
Inventor
Andrew Simon Craig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU7542800A publication Critical patent/AU7542800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU75428/00A 1999-10-04 2000-10-04 Process for the preparation of paroxetine hydrochloride acetone solvate Abandoned AU7542800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9923439.5A GB9923439D0 (en) 1999-10-04 1999-10-04 Novel process
GB9923439 1999-10-04
PCT/GB2000/003802 WO2001025232A1 (en) 1999-10-04 2000-10-04 Process for the preparation of paroxetine hydrochloride acetone solvate

Publications (1)

Publication Number Publication Date
AU7542800A true AU7542800A (en) 2001-05-10

Family

ID=10862092

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75428/00A Abandoned AU7542800A (en) 1999-10-04 2000-10-04 Process for the preparation of paroxetine hydrochloride acetone solvate

Country Status (3)

Country Link
AU (1) AU7542800A (en)
GB (1) GB9923439D0 (en)
WO (1) WO2001025232A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR001982A1 (en) * 1995-02-06 1998-01-07 Smithkline Beecham Plc PAROXETINE CHLORHYDRATE ANHYDRATED, AND PROCEDURE FOR ITS PREPARATION
NZ336587A (en) * 1997-01-15 2001-01-26 Smithkline Beecham P Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran
GB9726907D0 (en) * 1997-12-19 1998-02-18 Smithkline Beecham Plc Novel compounds
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process

Also Published As

Publication number Publication date
WO2001025232A1 (en) 2001-04-12
GB9923439D0 (en) 1999-12-08

Similar Documents

Publication Publication Date Title
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
NO20013569L (en) Process for the preparation of L-phenylephrine hydrochloride
AU6123099A (en) Process for the preparation of amine derivatives
AU1987400A (en) Process for preparation of paroxetine maleate
AU1573100A (en) Composition of paroxetine methanesulfonate
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
AU1037901A (en) Process for the preparation of paroxetine
AU3818900A (en) Process for the preparation of substituted piperidines
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
AU5553200A (en) Process for the preparation of paroxetine and structurally related compounds
AU1398500A (en) Process for the production of paroxetine hydrochloride propan-2-ol solvate
HUP0105482A3 (en) Process for the production of paroxetine
HUP0001558A3 (en) Process for the preparation of pirlindole hydrochloride
AU7542800A (en) Process for the preparation of paroxetine hydrochloride acetone solvate
AU7542500A (en) Process for the preparation of paroxetine hydrochloride acetone solvate
AU7542200A (en) Process for the preparation of paroxetine hydrochloride acetone solvate
HUP0004503A3 (en) Process for the preparation of paroxetine hydrochloride
AU1396400A (en) Process for the preparation of paroxetine hydrochloride
AU6481799A (en) Process for the preparation of paroxetine hydrochloride
AU1397800A (en) Method of producing paroxetine hydrochloride
AU1398100A (en) Process for the production of paroxetine hydrochloride acetone solvate
AU2001258718A1 (en) An improved process for the preparation of quinolone derivatives
AU6580800A (en) Process for the preparation of paroxetine hydrochloride
AU2155501A (en) Process for the preparation of ketimines
AU1130901A (en) Method for the preparation of 5-carboxyphthalide

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase